Streetbeat News

Analyst Ratings

LQDA

Analysts have provided ratings for Liquidia (NASDAQ:LQDA) in the last quarter, with 3 bullish and 1 somewhat bearish. The average 12-month price target for Liquidia is $13.75, a 23.61% decrease from the previous average price target of $18.00.

Portfolio Pulse from Benzinga Insights

June 28, 2023 | 7:00 pm

CME

In the last quarter, 5 analysts have provided ratings for CME Gr (NASDAQ:CME), with 2 being somewhat bullish, 2 indifferent, and 1 bearish. The company has an average 12-month price target of $199.8, a decrease of 1.74% from the previous average price target of $203.33.

Portfolio Pulse from Benzinga Insights

June 28, 2023 | 7:00 pm

LIFZF

Scotiabank analyst Orest Wowkodaw has maintained a 'Sector Perform' rating on Labrador Iron Ore Royalty (OTC:LIFZF) and lowered the price target from C$35 to C$34.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 6:59 pm

IVPAF

Scotiabank has maintained its 'Outperform' rating on Ivanhoe Mines (OTC:IVPAF) but lowered the price target from C$16 to C$15. The adjustment was announced by Scotiabank analyst Orest Wowkodaw.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 6:57 pm

NPIFF

Scotiabank analyst Justin Strong has maintained an Outperform rating on Northland Power (OTC:NPIFF) but lowered the price target from C$41.5 to C$37.5.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 6:54 pm

LLY

MDGL

MRK

TERN

VKTX

Terns Pharmaceuticals Inc (TERN) shares lost over 25% of their value due to investor pressure following Eli Lilly And Co's (LLY) announcement of positive obesity data from retatrutide. Despite this, JMP Securities maintains that TERN shares are attractively priced ahead of 3Q23 key NASH data, reiterating its Market Outperform rating and a price target of $17. Other companies in the space, Madrigal Pharmaceuticals Inc (MDGL) and Viking Therapeutics Inc (VKTX), also saw their shares drop. Merck Co & Inc's (MRK) efinopegdutide data showed a 73% reduction in liver fat.

Portfolio Pulse from Vandana Singh

June 28, 2023 | 6:53 pm

INGXF

Scotiabank analyst Justin Strong has maintained a 'Sector Perform' rating on Innergex Renewable Energy (OTC:INGXF) but lowered the price target from C$19.25 to C$17.25.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 6:52 pm

WBA

Walgreens Boots Alliance Inc (WBA) reported weaker-than-expected Q3 profits and lowered its FY23 adjusted EPS guidance to $4.00-$4.05 from the previous $4.45 - $4.65. Analysts from Truist Securities, Mizuho Securities, and Raymond James maintain a cautious stance on the company, citing disappointing quarter results and a cautious macroeconomic forward view.

Portfolio Pulse from Vandana Singh

June 28, 2023 | 6:50 pm

HBM

Scotiabank analyst Orest Wowkodaw has maintained an Outperform rating on Hudbay Minerals (NYSE:HBM) but lowered the price target from C$11 to C$10.5.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 6:49 pm

EXTR

Oppenheimer analyst Timothy Horan initiated coverage on Extreme Networks, Inc. (EXTR) with a price target of $35, citing attractive valuation and strong growth potential. Horan believes EXTR is well-positioned as an enterprise Edge Cloud and AI beneficiary and expects solid annual top-line revenue growth in the mid-to-high teens over the next several years. However, he also warns of potential supply chain issues, particularly prolonged semiconductor chip shortages.

Portfolio Pulse from Nabaparna Bhattacharya

June 28, 2023 | 6:48 pm